Market Overview

Oppenheimer Reiterates Outperform on Alimera Sciences, Inc., Lowers PT to $3.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ALIM

DateFirmActionFromTo
Mar 2016Cantor FitzgeraldMaintainsBuy
Jan 2016Cantor FitzgeraldMaintainsBuy
Nov 2014Summer StreetInitiates Coverage onBuy

View More Analyst Ratings for ALIM
View the Latest Analyst Ratings

Posted-In: News Reiteration Analyst Ratings

 

Related Articles (ALIM)